Population
T lymphocyte origin cells (Jurkat), fibroblasts, and adrenal carcinoma line (Y1)
Comparison
Chimeric expression construct replacing the… vs Endogenous AdoMetDC mRNA, or unmutated constructs
Design
Preclinical
Authors
Loading...
No immediate clinical implications from this animal study; leaves open uORF targeting in human T-cell disorders.
The uORF in the AdoMetDC 5'-transcript leader acts as a negative element modulating cell-specific polysomal distribution of its mRNA.
Hill et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: